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Abstract  
 
Background: Right heart enlargement is common in the athletes’ heart phenotype however 
few data exist regarding interpretation of normal athletic adaptation during Pre-participation 
Cardiac Screening (PCS) of Rugby Football League (RFL) athletes. Echocardiography is 
utilised during PCS and thus the primary aim of this study was to establish the normal right 
ventricular (RV) phenotype in elite RFL athletes using standard 2D echocardiography and 
myocardial mechanics. The secondary aim was to describe right atrial (RA) structure and 
function using 2D echocardiography. 
Methods: 139 male RFL athletes underwent echocardiographic evaluation of the right heart 
including RV strain (ɛ) and strain rate (SR) imaging using speckle tracking echocardiography 
(STE). Non-athletic males were used for comparison and allometric scaling was applied for 
conventional echocardiographic parameters. 
Results: Scaled RV dimensions were larger in athletes (P<0.05) with the exception of the 
mid cavity. No differences (P>0.05) in RV fractional area change (FAC) and RV longitudinal 
ɛ were observed between groups. Tissue Doppler imaging (TDI) indexed parameters and 
global strain rate (SR) were lower (P<0.05) in athletes with HR and weight found to have co-
variance with SR. The RA was larger in athletes (P<0.001) with no functional difference 
(P>0.05) observed by volume assessment. 
Conclusions: Reduction in SR and indexed TDI are partly associated with lower HR and 
increased body mass and are likely to represent normal physiological adaptation in RFL 
athletes. RA enlargement appears proportional to RV enlargement. These data may aid 
interpretation of normal athletic adaptation during PCS of RFL athletes.   
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Introduction 
 
Physiological cardiac adaptation that occurs in response to intense physical athletic training is 
known as the Athletes Heart (AH)1,2. Although the AH phenotype involves all cardiac 
chambers, the left ventricle (LV) has been the most extensively studied and reported in meta-
analyses1,2 with the impact of remodelling on the right ventricle (RV) and right atrium (RA) 
having received less attention3,4,5,6,7,8. RV enlargement is a common phenotype in AH but is 
also one of the diagnostic criteria for Arrhythmogenic Right Ventricular Cardiomyopathy 
(ARVC) a condition linked to sudden cardiac death (SCD)9,10. Echocardiography is utilised in 
the assessment of the RV during athletic pre-participation cardiac screening (PCS) but this 
can be challenging in the athlete due to the potential for physiological and pathological 
overlap. There are currently no comprehensive, sport-specific, echocardiographic data 
regarding the interpretation of normal RV athletic adaptation compared to non-athletic 
controls. 
Novel, functional, echocardiographic techniques including strain (ɛ) and strain rate (SR) 
imaging can assist clinical differentiation between normal physiologic RV adaptation and 
inherited pathological conditions such as ARVC11,12. There is, however, conflicting data 
defining the magnitude of RVɛ values in athletes with some studies reporting reduced 
RVɛ13,14,15 whilst others have reported normal values16,17. Normative, sport-specific RV ɛ and 
SR data alongside conventional 2D echocardiographic parameters may improve the utility of 
echocardiography in PCS. 
Only a few studies have investigated the RA phenotype in athletes5,6,7,8 with the consensus 
being an enlargement reflective of the physiological change in haemodynamic loading 
conditions5. Whilst RA enlargement is a recognised manifestation of the AH18 it also occurs 
in patients with increased filling pressures secondary to RV anomalies and cardiovascular 
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disease19. Enlargement can also be associated with atrial arrhythmias20,21,22 and 
cardiomyopathy23 and therefore the ability to define normal RA physiology in the athletic 
population is also clinically relevant.  
Rugby Football League (RFL) is a high intensity, intermittent sport with moderate static (10-
20%) and moderate dynamic (50-75%) components24. With recent high profile cases of SCD 
in RFL athletes and PCS being made mandatory for all male athletes competing in the 
professional RFL Super-League, it is pertinent to establish normative echocardiographic  
parameters of the right heart in this specific group of athletes. This may lead to increased 
sensitivity, specificity and diagnostic capability of echocardiography during PCS of RFL 
athletes. 
The primary aim of this study was to establish the RV phenotype in elite male RFL athletes 
using standard 2D, Doppler, tissue Doppler, ɛ and SR imaging. The secondary aim was to 
describe RA structure and function using 2D echocardiography.  
 
Methods 
Study population and design  
Following approval from the Ethics Committee of Liverpool John Moores University, 139 elite 
senior RFL Super-league athletes aged 24±4 years (range 19-34) and 52 sedentary control 
subjects 22±3 years (range 20–35) provided written informed consent to participate in the 
study. Athlete data was collected as part of their mandatory annual PCS. All athletes 
participated in more than 10 hours structured exercise training per week and controls were 
healthy individuals who were not involved in structured sport related training, engaging in less 
than 3 hours recreational activity per week. After a detailed explanation of the testing protocol 
participants completed a medical questionnaire to document any cardiovascular symptoms, 
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family history of SCD or other cardiovascular history. All participants abstained from exercise 
training or recreational activity for at least 6 hours prior to the investigation. They were allowed 
to take food and water ad libitum but were restricted from alcohol consumption 24 hours prior. 
A cross-sectional study was employed and data was acquired in a resting state at a single testing 
session. Screening results were reported by a sports cardiologist with clinical referrals made 
for any participant requiring further cardiac evaluation. On further evaluation no cardiac 
disease was present in any of the athletes or controls, allowing for all participants to be included 
in the study. 
Procedures 
Anthropometry 
A routine standard anthropometric assessment included height (Seca 217, Hannover, Germany) 
and body mass (Seca supra 719, Hannover, Germany) measurements with body surface area 
(BSA) calculated as previously described25. Resting blood pressure (BP) was assessed with an 
automated sphygmomanometer (Dinamap 300, GE Medical systems, USA). 
Conventional 2D Echocardiography 
All echocardiographic images were acquired using a commercially available ultrasound system 
(Vivid Q, GE Medical, Horten, Norway) with a 1.5-4 MHz phased array transducer. Two 
experienced sonographers acquired the images with the participant lying in the left lateral 
decubitas position in adherence to American Society of Echocardiography (ASE) guidelines26. 
Images were stored as a raw digital imaging and communications in medicine (DICOM) format 
and exported to an offline workstation (Echopac, Version 110.0.2, GE Healthcare, Horten, 
Norway) for subsequent analysis. Data was analysed by a single experienced sonographer and 
standard 2D, Doppler and pulsed wave tissue Doppler (TDI) measurements of chamber 
structure and function were made in accordance with ASE guidelines21,26.  
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Right Ventricle 
The RV outflow tract (RVOT) was measured at three locations (RVOTplax, RVOT1 and 
RVOT2) in the parasternal orientation. The RV inflow was measured from a modified (RV 
focused) apical four chamber orientation at end diastole at basal (RVD1) and mid (RVD2) levels 
and RV length (RVD3) measured from apex to base at the level of the tricuspid annulus (Figure 
1). The RVOT1:RVD1 ratio was calculated to establish the relative outflow and inflow 
dimensions. RV diastolic area (RVDa) and RV systolic area (RVSa) were measured from the 
same orientation and fractional area change calculated (RVFAC). RV free wall thickness was 
measured from the subcostal image with write-zoom applied to the RV mid wall taking care to 
avoid papillary muscle and trabeculation. Tricuspid annular plane systolic excursion (TAPSE) 
was measured and TDI allowed measurement of peak RV lateral systolic (RVS’), and early 
(RVE’) and late (RVA’) diastolic myocardial velocities. Peak RV TDI data was indexed for 
RV length by dividing by RVD3 to provide TDI index (RVS’index, RVE’index and 
RVA’index) as per recommendations for the LV27. The RV:LV ratio was subsequently 
determined from the measurement of the diameter of the base of both ventricles at end diastole 
from a standard apical 4 chamber image. 
Insert Figure 1  
 
 
Right Atrium 
RA area (RAa) and volume (RAVOL) was measured from the apical 4 chamber image by 
tracing the RA and by method of discs respectively21. Volumes were calculated at end 
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ventricular systole (RAVOLes), pre atrial contraction (RAVOLpreA) and end ventricular 
diastole (RAVOLed). These static volumes allowed the derivation of RA functional data and 
were assessed to provide reservoir (RAVOLres), conduit (RAVOLcon) and booster 
(RAVOLboo) volumes. RAVOLres was calculated as the difference between RAVOLes and 
RAVOLed. RAVOLcon was determined by difference between LV stroke volume (as this 
should equal RV stroke volume) (from Simpsons Biplane method) and RAVOLres. 
RAVOLboo was determined by difference between RAVOLpreA and RAVOLed8. The 
conduit to booster ratio (con:boo) was derived  as a measure of relative contributions to 
diastolic filling.  
 
All structural indices were scaled allometrically to BSA based on the principle of geometric 
similarity28. Linear dimensions were scaled to BSA0.5, areas directly to BSA and volumes to 
BSA1.5.  
Speckle Tracking Echocardiography (STE) 
Images for the assessment of myocardial ɛ and SR were acquired at frame rates between 40 
and 90 frames per second with settings adjusted to provide optimal endocardial delineation.  ɛ 
and SR were analysed by STE using an offline software package (Echopac, Version 110.0.2, 
GE Healthcare, Horten, Norway).   
The assessment of global and regional longitudinal ɛ and SR was achieved using the RV 
focused, modified apical four chamber image to track the lateral wall only. The region of 
interest (ROI) was placed from basal to apical wall encompassing three regional segments 
basal, mid and apical. RVɛ, time to peak RVɛ, systolic SR (RVSRS), early diastolic SR 
(RVSRE) and late diastolic SR (RVSRA) were assessed and an average was calculated to 
provide peak global longitudinal values29. Base to apex ɛ gradient was calculated as the 
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percentage difference between apical and basal ɛ. A previous study from our laboratory 
demonstrated excellent intra-observer reproducibility for RV ɛ with an intra-class correlation 
coefficient (ICC) of 0.834 and coefficient of variation (CoV) of 7%. RV SR was more variable 
but with an acceptable ICC of >0.6 and CoV of <15%30. 
Standardisation of STE Data 
The data was processed using cubic spline interpolation. All raw data was exported to allow a 
standardised, temporal assessment throughout the cardiac cycle. To account for inter or intra 
individual differences in heart rate, the data were normalised to the percentage of systolic and 
diastolic duration. RV ɛ and SR data were defined by 5% increments across systole and diastole 
and the peak value was reported.  
 
Statistical Analysis 
Study data were collected and managed using REDCAP electronic data capture tools hosted at 
Liverpool John Moores University31. All echocardiographic data were presented as mean ± SD 
and ranges. Statistical analyses were performed using the commercially available software 
package SPSS (SPSS, Version 23.0 for Windows, Illinois, USA). The Kolmogorov-Smirnov 
test highlighted normal distribution across all parameters and therefore variables were analysed 
between athletes and controls using independent T-tests with P<0.05 considered statistically 
significant. Where parameters met statistical significance an ANCOVA was performed with 
subsequent Bonferonni post-hoc tests to establish the impact of any co-variance from Age, HR, 
height and weight on functional RV STE parameters. A P<0.05 was considered statistically 
significant.  
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Results 
Athletes were slightly older than controls (P=0.001) but within the same age range. Height, 
weight and BSA were all greater (P<0.001) whilst HR was lower (P<0.001) in the athlete 
group. There was no difference in systolic BP (P=0.413) but diastolic BP was lower in athletes 
(P<0.001) (Table 1). 
 
Insert Table 1 
 
Right Ventricular Structure and Function  
RV standard structural and functional indices are presented in Table 2. All absolute measures 
of RV size including RVWT and the RV:LV ratio were larger (P<0.01) in the athlete compared 
to the control group. All parameters remained statistically significant following allometric 
scaling with exception of RVD2.  88% of athletes and 38% of controls met RVOTplax dimension 
criteria for ARVC10.  78% of athletes and 29% of controls met RVOT1 dimension criteria for 
ARVC10. None of the controls met major ARVC criteria for RVOT1 compared to 46% of 
athletes (Figure 2). The RVOT1:RVD1 ratio was increased in athletes (P=0.012). TAPSE and 
RVFAC were not significantly different between groups. Absolute RV systolic and diastolic 
TDI values - RVS’, RVE’, RVA’ and RV E’/A’ ratio were not different between groups 
however the associated indexed values for RVS’, RVE’ and RVA’ were lower in the athlete 
group (P=0.002, <0.001 and 0.015 respectively). 
 
Insert Table 2 and Figure 2 
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Global RV longitudinal ɛ, although lower in athletes, was not statistically significant between 
groups (Table 3, Figure 3).  Time to peak ɛ was higher (P<0.001) in the athlete group whilst 
RVSRS, RVSRE and RVSRA were all lower (P<0.001) in the athlete compared to the control 
group (Figure 3). 
 
Insert Table 3 and Figure 3 
 
There were no significant differences between groups for RV regional longitudinal ɛ (Table 3) 
and both groups exhibited similar apex to base ɛ gradients (-5%, P=0.743). In the athlete group, 
all 3 RV wall segments demonstrated lower RVSRS (basal P<0.001, mid P=0.004 and apical 
P<0.001) and RVSRA (Basal P=0.001, mid P=0.007 and apical P=0.003). Basal (P=0.001) and 
mid segments also demonstrated lower RVSRE (P<0.001) (Table 3). 
T-tests showed significant differences only in SR between groups. Following ANCOVA age 
was not found to alter statistical significance within SR between groups. HR did alter 
statistical significance and had an effect particularly on the S and A waves rendering the 
changes non-significant (Global RV SRS became non-significant (P = 0.061), basal and mid 
RV SRS and basal, mid and apical RV SRA (P > 0.05)). It is important to note that Eta 
squared i.e. estimated effect size were all less than 1-2% contribution. Height had no impact 
but weight altered significance for some regional parameters, rendering changes non-
significant (mid RV SRS, basal and apical RV SRE, mid and apical RV SRA (P > 0.05)). 
 
RA Structure and functional volumes 
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Absolute RAa, RAVOLes, RAVOLpreA and RAVOLed and their respective indexed values 
were larger in the athlete group compared to controls (P<0.001).  RAVOLres, RAVOLcon and 
RAVOLboo were larger in the athlete group (P<0.001) (Table 4) however con:boo was not 
different between groups (P=0.557). 
Insert Table 4 
 
Discussion 
The main findings of this study are 1) absolute measures for RV chamber size and wall 
thickness are greater in RFL athletes compared to sedentary controls. This finding remains 
following allometric scaling with the exception of RVD2. There are no differences in the 
functional parameters RVFAC and RV longitudinal ɛ between groups but TDI index and SR 
are lower in athletes, which are, in part, associated with lower HR and increased RV chamber 
size, and 2) all absolute and indexed structural RA parameters are greater in athletes. Whilst 
functional RA volumes are increased in athletes there is no difference in the relative 
contribution to diastolic filling. 
RV Structure  
Larger RV cavities in endurance athletes have been previously demonstrated with increases 
in both inflow and outflow dimensions6,16 however, there are few studies that have assessed 
the RV in resistance athletes or those involved in mixed training2. A 6 month resistance 
exercise training study demonstrated no increase in RV cavity dimensions32 and in a study by 
D’Andrea et al (2013)6 RV chamber size in resistance athletes were similar to sedentary 
controls.  The results of the current study in athletes with mixed endurance and resistance 
components would suggest that RV structure in the RFL athlete is more akin to that of the 
endurance athlete with an observed increased RV inflow and outflow dimensions and an 
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increased RV:LV ratio compared to controls. Unequal remodelling and increased RV:LV 
ratio has been reported previously in endurance athletes16,33,34 attributable to disproportionate 
loading on the RV during exercise34. The increased RVOT1:RVD1 ratio in athletes suggests a 
lack of proportional enlargement of RV outflow and inflow as RVOT1 appears to dilate to a 
greater extent. Differentiation of physiological RV enlargement from ARVC in RFL athletes 
is pertinent given that 88% and 78% of these meet ARVC criteria10 at RVOTplax and RVOT1 
respectively. 
Little attention has been paid to appropriate scaling of RV structural parameters but it is 
likely to aid interpretation of the RV in AH17. With appropriate scaling for body size in this 
study all structural parameters were significantly greater in athletes compared to controls, 
with the exception of RVD2. This would suggest that body size alone does not account for the 
enlarged RV in a RFL athlete.  
 
RV Function 
In addition to structural assessment, functional assessment is key when attempting to 
differentiate physiological RV remodelling from ARVC10.  It is considered best practice to 
apply a multifactorial approach to functional assessment including the use of TAPSE, 
RVFAC and RV TDI35. The current study reports no difference in TAPSE, RVFAC or 
standard indices of TDI between RFL athletes and controls and therefore the presence of 
abnormal values should prompt further investigation.  
 
ɛ imaging is advocated in the assessment of RV function21 and it has been reported that STE ɛ 
parameters are superior to conventional echocardiographic parameters in aiding the 
identification of ARVC11. No difference in longitudinal global RVɛ was noted between RFL 
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athletes and controls, providing additional support that a reduction in function is not a normal 
physiological response in RFL athletes. Lower global RVɛ values have been previously 
reported in elite endurance athletes due to reduction in basal function13, a finding that was 
reproduced in a subsequent study but with the additional finding of increased function in the 
apical segment ɛ14. In the current study there was no difference in regional RVɛ between 
groups and both RFL athletes and controls exhibit an RVɛ gradient of 5% from base to apex, 
suggesting a normal pattern of deformation even with increased RV size in RFL athletes. 
Other recent studies reported no difference in resting ɛ parameters16 and no differences in 
global or regional RV deformation in athletes compared to controls17. Similarly a study 
involving both endurance and resistance athletes found few meaningful differences in 
deformation parameters of the right heart irrespective of sporting discipline, training volume 
and physiological remodelling7.  
 
SR and TDI index are related to HR and RV dimensions. TDI index is reduced in athletes and 
despite regional SR showing similar distribution in both RFL athletes and controls, both 
global and regional SR is lower in athletes.  HR has been identified as a co-variance for 
global and regional SR parameters, predominantly RV SRS and RV SRA. These effects 
however are small as the estimated effect size were all less than 1-2%. Weight was also found 
to be a co-variance for some regional RV SR parameters. An increased body mass in athletes 
was expected and likely attributable to an increased fat free mass leading to increases in RV 
chamber size. Similarly, Forsythe et al (2018)36 reported a correlation between LV size and 
SR, were SR was also found to be lower in RFL athletes. In an endurance training study by 
Teske et al. (2009)13 SR values were found to be reduced in basal and mid segments in 
athletes with marked RV dilatation, whereas athletes without RV dilatation showed no 
significant difference compared to controls. It was reported that this should be interpreted as 
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a normal finding when evaluating athletes suspected for RV pathology13. Lower SR in 
athletes in the current study is also likely to represent normal physiological adaptation to 
training in the RFL athlete given that ɛ, TDI, RVFAC and TAPSE were not different 
compared to controls.  It has been previously reported that during brief maximal exercise the 
RV has the capacity to increase contractility to compensate for disproportionate increases in 
work34 and it is reasonable to speculate that reduced SR (aligned to chamber size and HR) 
may be an adaptation of myocardial contractility to support contractile reserve during 
exercise.  The increased size of the RV would suggest an increased RV mass and number of 
myofibrils and it is plausible that a greater number of myofibrils37 may reach the same 
required deformation at a slower rate, or in other words, a similar wall tension and 
intraventricular pressure can be generated or released at a slower speed. An increase in RV 
free wall thickness and a reduced contractile stress may result in the same contractile force. 
 
RA Structure and Function 
Increased RA area, volume and indexed volume has been reported in athletes with changes in 
the RA proportional to those of the RV5. McClean et al (2015)8 reported that RA size is 
consistently larger throughout the cardiac cycle, in athletes with high dynamic training. These 
data of both studies are supported by the current study. The RA assists RV filling by 1) acting 
as a reservoir for venous return, 2) acting as a passive conduit in early diastole and 3) acting as 
an active conduit (booster) in late diastole during atrial contraction21. During all 3 phases of 
RV filling, functional volumes, RAVOLres, RAVOLcon and RAVOLboo were greater in RFL 
athletes. This does not infer a functional RA improvement in RFL athletes as no difference in 
the con:boo volume ratio was found between groups. Although atrial enlargement appears to 
be a normal physiological response to dynamic training there is increasing evidence of an 
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association between an AH phenotype and autonomic alterations with atrial arrhythmia22. As 
mechanisms of atrial arrhythmia in the athlete are not clearly understood22,38, the RA is likely 
to receive more attention in the future. 
 
Limitations 
There is a significant difference in age between athletes and controls in this study however all 
athletes fit within an age decile that we utilise for normative echocardiographic parameters. It 
is expected to observe differences in height and weight between elite athletes and non-athletic 
controls and hence we have allometrically scaled all structural indices and performed 
ANCOVA to establish any effect on STE data. By inference an athlete will have a slower HR 
and thus we have provided temporally indexed peak strain data. The athletes were selected 
according to sporting discipline and these findings may not therefore be representative of all 
athletes. The athletes were male and data cannot be applied to female athletes. As a cross 
sectional study, the timing and development of exercise induced structural and functional 
adaptation cannot be determined and it is possible that seasonal variation in training may also 
affect cardiac evaluation.  
 
Conclusions 
This study provides a novel and comprehensive assessment of the right heart in the RFL 
athlete. RV dimensions are larger in athletes independent of body size, whilst reduced SR and 
indexed TDI is likely a normal physiological phenomenon in the elite RFL athletes. Lower 
SR in RFL athletes is in a small part related to HR and body size but these cannot fully 
explain the variance, particularly in the global SR parameters. Despite RA enlargement in 
RFL athletes we cannot infer a functional RA/RV improvement compared to controls. These 
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data may be used to aid differentiation between physiology and pathology during PCS of 
these athletes.   
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Table 2: Echocardiographic parameters of the right ventricle 
Table 3: Global and regional right ventricular ɛ and SR 
Table 4:  Echocardiographic parameters of the right atrium 
Figure 1: Measurement of RV structural dimensions. a, RVOTplax; b, RVOT1; c, RVOT2;  
d, RVD1, RVD2 and RVD3 
Figure 2: Percentage of athletes and controls meeting minor and major criteria for ARVC 
according to Marcus et al10 
Figure 3: Measurement of RV ɛ and SR. a, Athlete RV ɛ; b, Athlete RV SR; c, Control RV 
ɛ; d, Control RV SR. 
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Table 1: Demographics 
 
*denotes statistical significance at the level P<0.05 
BSA, Body Surface Area; HR, Heart Rate; BP, Blood Pressure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Athlete 
Mean±SD  
(Range) 
Control 
Mean±SD  
(Range) 
 
P value 
 
Age (Years) 24±4  
(19-34) 
22±3  
(20-35) 
0.001* 
Height (m) 1.82±0.06  
(1.62-1.98) 
1.78±0.06  
(1.65-1.91) 
<0.001* 
Weight (Kg) 96±11  
(75-132) 
78±9  
(60-107) 
<0.001* 
BSA (m2) 2.20±0.15  
(1.91-2.66) 
1.96±0.13  
(1.66-2.38) 
<0.001* 
HR (Beats.min-1) 56±10  
(39-83) 
69±9  
(50-95) 
<0.001* 
Systolic BP 131±9 
(107-155) 
129±10 
(113-151) 
0.413 
Diastolic BP 69±7 
(53-89) 
74±7 
(63-90) 
<0.001 
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Table 2:  Echocardiographic parameters of the right ventricle 
 Athlete 
Mean±SD  
(Range) 
Control 
Mean±SD  
(Range) 
 
P Value 
RVOTPLAX (mm) 34±4  
(21-47) 
28±4  
(20-36) 
<0.001* 
RVOT1 (mm) 36±5  
(22-49) 
29±4  
(19-35) 
<0.001* 
RVOT2 (mm) 27±3  
(19-35) 
23±2  
(18-28) 
<0.001* 
RVD1 (mm) 44±5  
(33-60) 
39±4  
(31-47) 
<0.001* 
RVD2 (mm) 33±4  
(22-44) 
30±5  
(17-42) 
<0.001* 
RVD3 (mm) 91±8  
(72-111) 
82±7  
(71-98) 
<0.001* 
RVDa (cm2) 30±4  
(21-41) 
22±3  
(15-29) 
<0.001* 
RVSa (cm2) 16±3  
(10-23) 
12±2  
(6-18) 
<0.001* 
RV WT (mm) 4±1  
(2-7) 
4±1  
(3-5) 
<0.001* 
TAPSE (mm) 24±4  
(16-33) 
23±3  
(17-32) 
0.144 
RVOT1:RVD1 
Ratio 
0.81±0.14 
(0.52-1.23) 
0.76±0.11 
(0.44-0.97) 
0.012* 
RV:LV Ratio 0.91±0.10  
(0.70-1.20) 
0.82±0.07  
(0.66-1.01) 
<0.001* 
RVFAC (%) 46±6  
(34-61) 
47±7  
(38-64) 
0.442 
RVOTPLAX 
(mm/(m2)0.5)) 
23±3  
(15-30) 
20±2  
(15-25) 
<0.001* 
RVOT1 
(mm/(m2)0.5)) 
24±3  
(15-32) 
21±3  
(14-26) 
<0.001* 
RVOT2 
(mm/(m2)0.5)) 
18±2  
(13-24) 
17±2  
(13-20) 
<0.001* 
RVD1 (mm/(m2)0.5)) 30±3  
(22-38) 
28±2  
(23-34) 
<0.001* 
RVD2 (mm/(m2)0.5)) 22±3  
(15-30) 
21±3  
(12-29) 
0.174 
RVD3 (mm/(m2)0.5)) 61±5  
(47-75) 
59±5  
(49-70) 
0.04* 
RVDa Index 
(cm2/m2) 
14±2  
(9-18) 
11±2  
(7-15) 
<0.001* 
RVSa Index 
(cm2/m2) 
7±1  
(4-11) 
6±1  
(3-8) 
<0.001* 
RVS' (cm/s) 15±2  14±2  0.581 
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(6-23) (10-18) 
RVE' (cm/s) 15±3  
(7-24) 
15±3  
(9-21) 
0.502 
RVA' (cm/s) 10±3  
(5-17) 
11±3  
(6-18) 
0.852 
RV E'/A' (cm/s) 1.54±0.44  
(0.71-3.00) 
1.56±0.49  
(0.81-2.71) 
0.775 
RVS' index 
((cm/s)/cm) 
1.61±0.29  
(0.61-2.44) 
1.75±0.26  
(1.06-2.34) 
0.002* 
RVE' index 
((cm/s)/cm) 
1.65±0.32  
(0.84-2.76) 
1.89±0.39  
(0.98-2.76) 
<0.001* 
RVA' index 
((cm/s)/cm) 
1.15±0.33  
(0.56-2.05) 
1.28±0.34  
(0.74-2.05) 
0.015* 
 
*denotes statistical significance at the level P<0.05 
RVOTPLAX, Right ventricular outflow tract at parasternal long axis; RVOT1, Right ventricular 
outflow tract (proximal); RVOT2, Right ventricular outflow tract (distal); RVD1, Right 
ventricular dimension (basal); RVD2, Right ventricular dimension (mid); RVD3, Right 
ventricular length; RVDa, Right ventricular diastolic area; RVSa, Right ventricular systolic 
area; TAPSE, Tricuspid annular plane systolic excursion; RV:LV ratio, Right ventricular to 
left ventricular ratio; RVFAC, Right ventricular fractional area change; RVS’, RV TDI lateral 
systolic myocardial velocity; RVE’, RV TDI early diastolic myocardial velocity; RVA’, RV 
TDI late diastolic myocardial velocity.  
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Table 3:  Global and regional right ventricular ɛ and SR 
 
 Athlete 
mean ± SD 
(Range) 
 
Control 
mean ± SD 
(Range) 
P Value 
 
Global RVɛ (%) 
 
-27.2±3.4  
(-18.4 to -40.7) 
-28.4±4.2  
(-19.1 to -41.2) 
0.053 
Time to Peak RV ɛ 
(s) 
0.38±0.03  
(0.31-0.46) 
0.36±0.03  
(0.31-0.44) 
<0.001* 
RVSRS (s-1) 
 
-1.32±0.22  
(-0.77 to -2.19) 
-1.48±0.28  
(-0.97 to -2.34) 
<0.001* 
RVSRE (s-1) 
 
1.59±0.33  
(0.79-2.67) 
1.92±0.50  
(1.11-3.26) 
<0.001* 
RVSRA (s-1) 
 
0.89±0.27  
(0.34-1.77) 
1.09±0.28  
(0.39-1.85) 
<0.001* 
Basal RVɛ (%) -24.9±5.4 -26.3±4.9 0.105 
Mid RVɛ (%) -27.2±4.1 -28.4±4.8 0.096 
Apical RVɛ (%) -30.0±4.3 -31.1±4.6 0.146 
Apex to Base RVɛ 
gradient (%) 
-5.2±6.9 -4.8±5.0 0.743 
Basal RVSRS (s-1) -1.50±0.41 -1.74±0.41 <0.001* 
Mid RVSRS (s-1) -1.37±0.27 -1.50±0.31 0.004* 
Apical RVSRS ( s-1) -1.58±0.31 -1.86±0.43 <0.001* 
Basal RVSRE (s-1) 2.10±0.67 2.50±0.84 0.001* 
Mid RVSRE (s-1) 1.68±0.40 2.02±0.58 <0.001* 
Apical RVSRE (s-1) 2.07±0.55 2.22±0.54 0.081 
Basal RVSRA (s-1) 1.06±0.34 1.26±0.38 0.001* 
Mid RVSRA (s-1) 0.98±0.33 1.13±0.37 0.007* 
Apical RVSRA (s-1) 1.25±0.40 1.46±0.44 0.003* 
 
 
*denotes statistical significance at the level P<0.05 
RVɛ, Right ventricular longitudinal strain; RVSRS, Right ventricular systolic strain rate, 
RVSRE, Right ventricular early diastolic strain rate; RVSRA, Right ventricular late diastolic 
strain rate. 
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Table 4:  Echocardiographic parameters of the Right Atrium 
 Athlete 
Mean±SD  
(Range) 
Control 
Mean±SD  
(Range) 
 
P Value 
RAa (cm2) 22±4  
(13-29) 
15±2  
(10-20) 
<0.001* 
RAa Index 
(cm2/m2) 
10±1  
(6-13) 
8±1  
(5-10) 
<0.001* 
RAVOLes (ml) 73±18  
(33-121) 
44±10  
(25-63) 
<0.001* 
RAVOLes Index 
(ml/(m2)1.5)) 
22±5  
(11-35) 
16±4  
(10-24) 
<0.001* 
RAVOLpreA (ml) 49±13  
(25-92) 
28±7  
(14-45) 
<0.001* 
RAVOLpreA Index 
(ml/(m2)1.5)) 
15±4  
(6-27) 
10±2  
(6-16) 
<0.001* 
RAVOLed (ml) 35±10  
(15-75) 
18±5  
(7-32) 
<0.001* 
RAVOLed Index 
(ml/(m2)1.5)) 
10±3  
(5-22) 
6±2  
(3-10) 
<0.001* 
RAVOLres (ml) 39±11  
(13-77) 
26±7  
(13-44) 
<0.001* 
RAVOLcon (ml) 53±17  
(5-96) 
36±12  
(12-65) 
<0.001* 
RAVOLboo (ml) 14±5  
(5-30) 
10±3  
(4-19) 
<0.001* 
Con : Boo Ratio 4.32±2.65 
(0.17-16.2) 
4.07±2.27 
(1.2-12.75) 
0.557 
 
*denotes statistical significance at the level P<0.05 
RAa, Right atrial area, RAVOLes, Right atrial end systolic volume; RAVOLpreA, Right 
atrial volume pre-atrial contraction; RAVOLed, Right atrial end diastolic volume; 
RAVOLres, Right atrial reservoir volume; RAVOLcon, Right atrial conduit volume; 
RAVOLboo, Right atrial booster volume; Con:Boo ratio, Conduit to booster volume ratio. 
 
 
 
 
 
